...
首页> 外文期刊>International Journal of Materials and Chemistry >In vitro Bioactivity of Polycaprolactone/Bioglass Composites
【24h】

In vitro Bioactivity of Polycaprolactone/Bioglass Composites

机译:聚己内酯/生物玻璃复合材料的体外生物活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A series of Polycaprolactone and Bioglass in the 85SiO2-10CaO-5P2O5 (mol. %) systems were synthesized at different quantity of the organic/inorganic components. The 85S Bioglass was prepared via sol-gel method. It was added to the Polycaprolactone matrix at 20, 50 and 80 weight (wt.) %, respectively. In vitro bioactivity of the prepared composites was evaluated in 1.5 Simulated Body Fluid (1.5 SBF). The obtained composite materials before and after static in vitro test were characterized by FTIR and SEM. The obtained experimental data proved that the synthesized composites exhibit good in vitro bioactivity. After immersion in 1.5SBF, SEM depicts the presence of nano-needle-like hydroxyapatite on the immersed 20PCL/80BG and 50PCL/50BG samples.
机译:在85SiO 2 -10CaO-5P2O 5 (摩尔%)体系中,以不同数量的有机/无机组分合成了一系列的聚己内酯和生物玻璃。 85S生物玻璃是通过溶胶-凝胶法制备的。将其分别以20、50和80重量(wt。)%添加到聚己内酯基质中。在1.5模拟体液(1.5 SBF)中评估了制备的复合材料的体外生物活性。用FTIR和SEM对静态测试前后得到的复合材料进行了表征。获得的实验数据证明合成的复合材料具有良好的体外生物活性。浸入1.5SBF后,SEM描绘了浸入的20PCL / 80BG和50PCL / 50BG样品中存在纳米针状羟基磷灰石。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号